The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Resolution Directing Use of Compulsory Process Regarding Proposed Mergers, Acquisitions, and Transactions Subject to Premerger Notification
Resolution Directing Use of Compulsory Process Regarding Any Persons, Partnerships, and Corporations Subject to Prior Commission Orders
Resolution Directing Use of Compulsory Process Regarding Acts or Practices Related to Technology Platforms
Facebook’s cover for Independent Assessor’s initial assessment
Independent Privacy Program Assessment Report
Statement of Commissioner Rohit Chopra Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding the Adoption of the Final Made in USA Rule
Remarks of Chair Lina M. Khan on the Investigatory Resolutions
Statement of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Rohit Chopra Regarding the Adoption of Revised Section 18 Rulemaking Procedures
Statement of Chair Lina M. Khan Joined by Commissioner Rohit Chopra and Commissioner Rebecca Kelly Slaughter on the Withdrawal of the Statement of Enforcement Principles Regarding “Unfair Methods of Competition” Under Section 5 of the FTC Act
Dissenting Statement of Commissioner Christine S. Wilson
Dissenting Remarks of Commissioner Noah Joshua Phillips Regarding the Commission’s Withdrawal of the Section 5 Policy Statement
Dissenting Remarks of Commissioner Noah Joshua Phillips Regarding the Commission's Issuance of Seven Omnibus Resolution
Quincy Bioscience Holding Company
The FTC and New York State AG have charged the marketers of the dietary supplement Prevagen with making false and unsubstantiated claims that the product improves memory, provides cognitive benefits, and is “clinically shown” to work.